Global Biologic Medication in COVID-19 Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Biologic Medication in COVID-19 market size was valued at US$ million in 2023. With growing demand in downstream market, the Biologic Medication in COVID-19 is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biologic Medication in COVID-19 market. Biologic Medication in COVID-19 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biologic Medication in COVID-19. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biologic Medication in COVID-19 market.
According to China's clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biologic Medication in COVID-19 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biologic Medication in COVID-19 market. It may include historical data, market segmentation by Type (e.g., Neutralizing Antibodies, Anti-inflammatory Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biologic Medication in COVID-19 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biologic Medication in COVID-19 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biologic Medication in COVID-19 industry. This include advancements in Biologic Medication in COVID-19 technology, Biologic Medication in COVID-19 new entrants, Biologic Medication in COVID-19 new investment, and other innovations that are shaping the future of Biologic Medication in COVID-19.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biologic Medication in COVID-19 market. It includes factors influencing customer ' purchasing decisions, preferences for Biologic Medication in COVID-19 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biologic Medication in COVID-19 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biologic Medication in COVID-19 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biologic Medication in COVID-19 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biologic Medication in COVID-19 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biologic Medication in COVID-19 market.
Market Segmentation:
Biologic Medication in COVID-19 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Biologic Medication in COVID-19 market size was valued at US$ million in 2023. With growing demand in downstream market, the Biologic Medication in COVID-19 is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biologic Medication in COVID-19 market. Biologic Medication in COVID-19 are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biologic Medication in COVID-19. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biologic Medication in COVID-19 market.
According to China's clinical trials of COVID-19 treatment, the number of chemical drugs accounted for the highest proportion, followed by biological drugs, cell therapy, vaccines, and traditional Chinese medicine. Among the biological drugs, IL-6 related monoclonal antibodies (anti-inflammatory) account for the largest proportion, including tocilizumab and Sarilumab. This report focuses on the investigation and analysis of biologic medication and predicts the future market development of biopharmaceuticals under the influence of COVID-19. Biological drugs are mainly divided into two categories: neutralizing antibodies and anti-inflammatory drugs. The main subdivisions include: IL-6, C5a, CD147, PD-1 and Interferon (beta-1a), etc.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biologic Medication in COVID-19 market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biologic Medication in COVID-19 market. It may include historical data, market segmentation by Type (e.g., Neutralizing Antibodies, Anti-inflammatory Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biologic Medication in COVID-19 market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biologic Medication in COVID-19 market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biologic Medication in COVID-19 industry. This include advancements in Biologic Medication in COVID-19 technology, Biologic Medication in COVID-19 new entrants, Biologic Medication in COVID-19 new investment, and other innovations that are shaping the future of Biologic Medication in COVID-19.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biologic Medication in COVID-19 market. It includes factors influencing customer ' purchasing decisions, preferences for Biologic Medication in COVID-19 product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biologic Medication in COVID-19 market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biologic Medication in COVID-19 market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biologic Medication in COVID-19 market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biologic Medication in COVID-19 industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biologic Medication in COVID-19 market.
Market Segmentation:
Biologic Medication in COVID-19 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Neutralizing Antibodies
- Anti-inflammatory Drugs
- COVID-19
- Influenza
- Malaria
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Sanofi
- Novartis
- Merck
- Bayer
- Shutaishen
- Biogen
- Regeneron Pharmaceuticals
- Vir Biotech
- Junshi Biosciences
- Anke Biotechnology
- OncoImmune
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Medication in COVID-19 Market Size 2019-2030
2.1.2 Biologic Medication in COVID-19 Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologic Medication in COVID-19 Segment by Type
2.2.1 Neutralizing Antibodies
2.2.2 Anti-inflammatory Drugs
2.3 Biologic Medication in COVID-19 Market Size by Type
2.3.1 Biologic Medication in COVID-19 Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
2.4 Biologic Medication in COVID-19 Segment by Application
2.4.1 COVID-19
2.4.2 Influenza
2.4.3 Malaria
2.4.4 Others
2.5 Biologic Medication in COVID-19 Market Size by Application
2.5.1 Biologic Medication in COVID-19 Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
3 BIOLOGIC MEDICATION IN COVID-19 MARKET SIZE BY PLAYER
3.1 Biologic Medication in COVID-19 Market Size Market Share by Players
3.1.1 Global Biologic Medication in COVID-19 Revenue by Players (2019-2024)
3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2019-2024)
3.2 Global Biologic Medication in COVID-19 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGIC MEDICATION IN COVID-19 BY REGIONS
4.1 Biologic Medication in COVID-19 Market Size by Regions (2019-2024)
4.2 Americas Biologic Medication in COVID-19 Market Size Growth (2019-2024)
4.3 APAC Biologic Medication in COVID-19 Market Size Growth (2019-2024)
4.4 Europe Biologic Medication in COVID-19 Market Size Growth (2019-2024)
4.5 Middle East & Africa Biologic Medication in COVID-19 Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biologic Medication in COVID-19 Market Size by Country (2019-2024)
5.2 Americas Biologic Medication in COVID-19 Market Size by Type (2019-2024)
5.3 Americas Biologic Medication in COVID-19 Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Medication in COVID-19 Market Size by Region (2019-2024)
6.2 APAC Biologic Medication in COVID-19 Market Size by Type (2019-2024)
6.3 APAC Biologic Medication in COVID-19 Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologic Medication in COVID-19 by Country (2019-2024)
7.2 Europe Biologic Medication in COVID-19 Market Size by Type (2019-2024)
7.3 Europe Biologic Medication in COVID-19 Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Medication in COVID-19 by Region (2019-2024)
8.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2019-2024)
8.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGIC MEDICATION IN COVID-19 MARKET FORECAST
10.1 Global Biologic Medication in COVID-19 Forecast by Regions (2025-2030)
10.1.1 Global Biologic Medication in COVID-19 Forecast by Regions (2025-2030)
10.1.2 Americas Biologic Medication in COVID-19 Forecast
10.1.3 APAC Biologic Medication in COVID-19 Forecast
10.1.4 Europe Biologic Medication in COVID-19 Forecast
10.1.5 Middle East & Africa Biologic Medication in COVID-19 Forecast
10.2 Americas Biologic Medication in COVID-19 Forecast by Country (2025-2030)
10.2.1 United States Biologic Medication in COVID-19 Market Forecast
10.2.2 Canada Biologic Medication in COVID-19 Market Forecast
10.2.3 Mexico Biologic Medication in COVID-19 Market Forecast
10.2.4 Brazil Biologic Medication in COVID-19 Market Forecast
10.3 APAC Biologic Medication in COVID-19 Forecast by Region (2025-2030)
10.3.1 China Biologic Medication in COVID-19 Market Forecast
10.3.2 Japan Biologic Medication in COVID-19 Market Forecast
10.3.3 Korea Biologic Medication in COVID-19 Market Forecast
10.3.4 Southeast Asia Biologic Medication in COVID-19 Market Forecast
10.3.5 India Biologic Medication in COVID-19 Market Forecast
10.3.6 Australia Biologic Medication in COVID-19 Market Forecast
10.4 Europe Biologic Medication in COVID-19 Forecast by Country (2025-2030)
10.4.1 Germany Biologic Medication in COVID-19 Market Forecast
10.4.2 France Biologic Medication in COVID-19 Market Forecast
10.4.3 UK Biologic Medication in COVID-19 Market Forecast
10.4.4 Italy Biologic Medication in COVID-19 Market Forecast
10.4.5 Russia Biologic Medication in COVID-19 Market Forecast
10.5 Middle East & Africa Biologic Medication in COVID-19 Forecast by Region (2025-2030)
10.5.1 Egypt Biologic Medication in COVID-19 Market Forecast
10.5.2 South Africa Biologic Medication in COVID-19 Market Forecast
10.5.3 Israel Biologic Medication in COVID-19 Market Forecast
10.5.4 Turkey Biologic Medication in COVID-19 Market Forecast
10.5.5 GCC Countries Biologic Medication in COVID-19 Market Forecast
10.6 Global Biologic Medication in COVID-19 Forecast by Type (2025-2030)
10.7 Global Biologic Medication in COVID-19 Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Biologic Medication in COVID-19 Product Offered
11.1.3 Roche Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Biologic Medication in COVID-19 Product Offered
11.2.3 Sanofi Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Biologic Medication in COVID-19 Product Offered
11.3.3 Novartis Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Biologic Medication in COVID-19 Product Offered
11.4.3 Merck Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Biologic Medication in COVID-19 Product Offered
11.5.3 Bayer Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Shutaishen
11.6.1 Shutaishen Company Information
11.6.2 Shutaishen Biologic Medication in COVID-19 Product Offered
11.6.3 Shutaishen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Shutaishen Main Business Overview
11.6.5 Shutaishen Latest Developments
11.7 Biogen
11.7.1 Biogen Company Information
11.7.2 Biogen Biologic Medication in COVID-19 Product Offered
11.7.3 Biogen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biogen Main Business Overview
11.7.5 Biogen Latest Developments
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Information
11.8.2 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product Offered
11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Regeneron Pharmaceuticals Main Business Overview
11.8.5 Regeneron Pharmaceuticals Latest Developments
11.9 Vir Biotech
11.9.1 Vir Biotech Company Information
11.9.2 Vir Biotech Biologic Medication in COVID-19 Product Offered
11.9.3 Vir Biotech Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Vir Biotech Main Business Overview
11.9.5 Vir Biotech Latest Developments
11.10 Junshi Biosciences
11.10.1 Junshi Biosciences Company Information
11.10.2 Junshi Biosciences Biologic Medication in COVID-19 Product Offered
11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Junshi Biosciences Main Business Overview
11.10.5 Junshi Biosciences Latest Developments
11.11 Anke Biotechnology
11.11.1 Anke Biotechnology Company Information
11.11.2 Anke Biotechnology Biologic Medication in COVID-19 Product Offered
11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Anke Biotechnology Main Business Overview
11.11.5 Anke Biotechnology Latest Developments
11.12 OncoImmune
11.12.1 OncoImmune Company Information
11.12.2 OncoImmune Biologic Medication in COVID-19 Product Offered
11.12.3 OncoImmune Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 OncoImmune Main Business Overview
11.12.5 OncoImmune Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Medication in COVID-19 Market Size 2019-2030
2.1.2 Biologic Medication in COVID-19 Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologic Medication in COVID-19 Segment by Type
2.2.1 Neutralizing Antibodies
2.2.2 Anti-inflammatory Drugs
2.3 Biologic Medication in COVID-19 Market Size by Type
2.3.1 Biologic Medication in COVID-19 Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
2.4 Biologic Medication in COVID-19 Segment by Application
2.4.1 COVID-19
2.4.2 Influenza
2.4.3 Malaria
2.4.4 Others
2.5 Biologic Medication in COVID-19 Market Size by Application
2.5.1 Biologic Medication in COVID-19 Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
3 BIOLOGIC MEDICATION IN COVID-19 MARKET SIZE BY PLAYER
3.1 Biologic Medication in COVID-19 Market Size Market Share by Players
3.1.1 Global Biologic Medication in COVID-19 Revenue by Players (2019-2024)
3.1.2 Global Biologic Medication in COVID-19 Revenue Market Share by Players (2019-2024)
3.2 Global Biologic Medication in COVID-19 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGIC MEDICATION IN COVID-19 BY REGIONS
4.1 Biologic Medication in COVID-19 Market Size by Regions (2019-2024)
4.2 Americas Biologic Medication in COVID-19 Market Size Growth (2019-2024)
4.3 APAC Biologic Medication in COVID-19 Market Size Growth (2019-2024)
4.4 Europe Biologic Medication in COVID-19 Market Size Growth (2019-2024)
4.5 Middle East & Africa Biologic Medication in COVID-19 Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biologic Medication in COVID-19 Market Size by Country (2019-2024)
5.2 Americas Biologic Medication in COVID-19 Market Size by Type (2019-2024)
5.3 Americas Biologic Medication in COVID-19 Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Medication in COVID-19 Market Size by Region (2019-2024)
6.2 APAC Biologic Medication in COVID-19 Market Size by Type (2019-2024)
6.3 APAC Biologic Medication in COVID-19 Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologic Medication in COVID-19 by Country (2019-2024)
7.2 Europe Biologic Medication in COVID-19 Market Size by Type (2019-2024)
7.3 Europe Biologic Medication in COVID-19 Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Medication in COVID-19 by Region (2019-2024)
8.2 Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2019-2024)
8.3 Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGIC MEDICATION IN COVID-19 MARKET FORECAST
10.1 Global Biologic Medication in COVID-19 Forecast by Regions (2025-2030)
10.1.1 Global Biologic Medication in COVID-19 Forecast by Regions (2025-2030)
10.1.2 Americas Biologic Medication in COVID-19 Forecast
10.1.3 APAC Biologic Medication in COVID-19 Forecast
10.1.4 Europe Biologic Medication in COVID-19 Forecast
10.1.5 Middle East & Africa Biologic Medication in COVID-19 Forecast
10.2 Americas Biologic Medication in COVID-19 Forecast by Country (2025-2030)
10.2.1 United States Biologic Medication in COVID-19 Market Forecast
10.2.2 Canada Biologic Medication in COVID-19 Market Forecast
10.2.3 Mexico Biologic Medication in COVID-19 Market Forecast
10.2.4 Brazil Biologic Medication in COVID-19 Market Forecast
10.3 APAC Biologic Medication in COVID-19 Forecast by Region (2025-2030)
10.3.1 China Biologic Medication in COVID-19 Market Forecast
10.3.2 Japan Biologic Medication in COVID-19 Market Forecast
10.3.3 Korea Biologic Medication in COVID-19 Market Forecast
10.3.4 Southeast Asia Biologic Medication in COVID-19 Market Forecast
10.3.5 India Biologic Medication in COVID-19 Market Forecast
10.3.6 Australia Biologic Medication in COVID-19 Market Forecast
10.4 Europe Biologic Medication in COVID-19 Forecast by Country (2025-2030)
10.4.1 Germany Biologic Medication in COVID-19 Market Forecast
10.4.2 France Biologic Medication in COVID-19 Market Forecast
10.4.3 UK Biologic Medication in COVID-19 Market Forecast
10.4.4 Italy Biologic Medication in COVID-19 Market Forecast
10.4.5 Russia Biologic Medication in COVID-19 Market Forecast
10.5 Middle East & Africa Biologic Medication in COVID-19 Forecast by Region (2025-2030)
10.5.1 Egypt Biologic Medication in COVID-19 Market Forecast
10.5.2 South Africa Biologic Medication in COVID-19 Market Forecast
10.5.3 Israel Biologic Medication in COVID-19 Market Forecast
10.5.4 Turkey Biologic Medication in COVID-19 Market Forecast
10.5.5 GCC Countries Biologic Medication in COVID-19 Market Forecast
10.6 Global Biologic Medication in COVID-19 Forecast by Type (2025-2030)
10.7 Global Biologic Medication in COVID-19 Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Biologic Medication in COVID-19 Product Offered
11.1.3 Roche Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Biologic Medication in COVID-19 Product Offered
11.2.3 Sanofi Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Biologic Medication in COVID-19 Product Offered
11.3.3 Novartis Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Biologic Medication in COVID-19 Product Offered
11.4.3 Merck Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Biologic Medication in COVID-19 Product Offered
11.5.3 Bayer Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Shutaishen
11.6.1 Shutaishen Company Information
11.6.2 Shutaishen Biologic Medication in COVID-19 Product Offered
11.6.3 Shutaishen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Shutaishen Main Business Overview
11.6.5 Shutaishen Latest Developments
11.7 Biogen
11.7.1 Biogen Company Information
11.7.2 Biogen Biologic Medication in COVID-19 Product Offered
11.7.3 Biogen Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Biogen Main Business Overview
11.7.5 Biogen Latest Developments
11.8 Regeneron Pharmaceuticals
11.8.1 Regeneron Pharmaceuticals Company Information
11.8.2 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product Offered
11.8.3 Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Regeneron Pharmaceuticals Main Business Overview
11.8.5 Regeneron Pharmaceuticals Latest Developments
11.9 Vir Biotech
11.9.1 Vir Biotech Company Information
11.9.2 Vir Biotech Biologic Medication in COVID-19 Product Offered
11.9.3 Vir Biotech Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Vir Biotech Main Business Overview
11.9.5 Vir Biotech Latest Developments
11.10 Junshi Biosciences
11.10.1 Junshi Biosciences Company Information
11.10.2 Junshi Biosciences Biologic Medication in COVID-19 Product Offered
11.10.3 Junshi Biosciences Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Junshi Biosciences Main Business Overview
11.10.5 Junshi Biosciences Latest Developments
11.11 Anke Biotechnology
11.11.1 Anke Biotechnology Company Information
11.11.2 Anke Biotechnology Biologic Medication in COVID-19 Product Offered
11.11.3 Anke Biotechnology Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Anke Biotechnology Main Business Overview
11.11.5 Anke Biotechnology Latest Developments
11.12 OncoImmune
11.12.1 OncoImmune Company Information
11.12.2 OncoImmune Biologic Medication in COVID-19 Product Offered
11.12.3 OncoImmune Biologic Medication in COVID-19 Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 OncoImmune Main Business Overview
11.12.5 OncoImmune Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologic Medication in COVID-19 Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Neutralizing Antibodies
Table 3. Major Players of Anti-inflammatory Drugs
Table 4. Biologic Medication in COVID-19 Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 7. Biologic Medication in COVID-19 Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 10. Global Biologic Medication in COVID-19 Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Biologic Medication in COVID-19 Revenue Market Share by Player (2019-2024)
Table 12. Biologic Medication in COVID-19 Key Players Head office and Products Offered
Table 13. Biologic Medication in COVID-19 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biologic Medication in COVID-19 Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Biologic Medication in COVID-19 Market Size Market Share by Regions (2019-2024)
Table 18. Global Biologic Medication in COVID-19 Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Biologic Medication in COVID-19 Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Biologic Medication in COVID-19 Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Biologic Medication in COVID-19 Market Size Market Share by Country (2019-2024)
Table 22. Americas Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 24. Americas Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 26. APAC Biologic Medication in COVID-19 Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Biologic Medication in COVID-19 Market Size Market Share by Region (2019-2024)
Table 28. APAC Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 30. APAC Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 32. Europe Biologic Medication in COVID-19 Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Biologic Medication in COVID-19 Market Size Market Share by Country (2019-2024)
Table 34. Europe Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 36. Europe Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Biologic Medication in COVID-19 Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Biologic Medication in COVID-19
Table 45. Key Market Challenges & Risks of Biologic Medication in COVID-19
Table 46. Key Industry Trends of Biologic Medication in COVID-19
Table 47. Global Biologic Medication in COVID-19 Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Biologic Medication in COVID-19 Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Biologic Medication in COVID-19 Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Roche Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 52. Roche Biologic Medication in COVID-19 Product Offered
Table 53. Roche Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Sanofi Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 57. Sanofi Biologic Medication in COVID-19 Product Offered
Table 58. Sanofi Main Business
Table 59. Sanofi Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Sanofi Latest Developments
Table 61. Novartis Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 62. Novartis Biologic Medication in COVID-19 Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Merck Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 67. Merck Biologic Medication in COVID-19 Product Offered
Table 68. Merck Main Business
Table 69. Merck Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Merck Latest Developments
Table 71. Bayer Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 72. Bayer Biologic Medication in COVID-19 Product Offered
Table 73. Bayer Main Business
Table 74. Bayer Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bayer Latest Developments
Table 76. Shutaishen Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 77. Shutaishen Biologic Medication in COVID-19 Product Offered
Table 78. Shutaishen Main Business
Table 79. Shutaishen Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Shutaishen Latest Developments
Table 81. Biogen Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 82. Biogen Biologic Medication in COVID-19 Product Offered
Table 83. Biogen Main Business
Table 84. Biogen Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Biogen Latest Developments
Table 86. Regeneron Pharmaceuticals Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 87. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product Offered
Table 88. Regeneron Pharmaceuticals Main Business
Table 89. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Regeneron Pharmaceuticals Latest Developments
Table 91. Vir Biotech Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 92. Vir Biotech Biologic Medication in COVID-19 Product Offered
Table 93. Vir Biotech Main Business
Table 94. Vir Biotech Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Vir Biotech Latest Developments
Table 96. Junshi Biosciences Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 97. Junshi Biosciences Biologic Medication in COVID-19 Product Offered
Table 98. Junshi Biosciences Main Business
Table 99. Junshi Biosciences Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Junshi Biosciences Latest Developments
Table 101. Anke Biotechnology Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 102. Anke Biotechnology Biologic Medication in COVID-19 Product Offered
Table 103. Anke Biotechnology Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Anke Biotechnology Main Business
Table 105. Anke Biotechnology Latest Developments
Table 106. OncoImmune Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 107. OncoImmune Biologic Medication in COVID-19 Product Offered
Table 108. OncoImmune Main Business
Table 109. OncoImmune Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. OncoImmune Latest Developments
Table 1. Biologic Medication in COVID-19 Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Neutralizing Antibodies
Table 3. Major Players of Anti-inflammatory Drugs
Table 4. Biologic Medication in COVID-19 Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 7. Biologic Medication in COVID-19 Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 10. Global Biologic Medication in COVID-19 Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Biologic Medication in COVID-19 Revenue Market Share by Player (2019-2024)
Table 12. Biologic Medication in COVID-19 Key Players Head office and Products Offered
Table 13. Biologic Medication in COVID-19 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Biologic Medication in COVID-19 Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Biologic Medication in COVID-19 Market Size Market Share by Regions (2019-2024)
Table 18. Global Biologic Medication in COVID-19 Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Biologic Medication in COVID-19 Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Biologic Medication in COVID-19 Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Biologic Medication in COVID-19 Market Size Market Share by Country (2019-2024)
Table 22. Americas Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 24. Americas Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 26. APAC Biologic Medication in COVID-19 Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Biologic Medication in COVID-19 Market Size Market Share by Region (2019-2024)
Table 28. APAC Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 30. APAC Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 32. Europe Biologic Medication in COVID-19 Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Biologic Medication in COVID-19 Market Size Market Share by Country (2019-2024)
Table 34. Europe Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 36. Europe Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Biologic Medication in COVID-19 Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Biologic Medication in COVID-19 Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Biologic Medication in COVID-19 Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Biologic Medication in COVID-19
Table 45. Key Market Challenges & Risks of Biologic Medication in COVID-19
Table 46. Key Industry Trends of Biologic Medication in COVID-19
Table 47. Global Biologic Medication in COVID-19 Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Biologic Medication in COVID-19 Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Biologic Medication in COVID-19 Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Roche Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 52. Roche Biologic Medication in COVID-19 Product Offered
Table 53. Roche Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. Sanofi Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 57. Sanofi Biologic Medication in COVID-19 Product Offered
Table 58. Sanofi Main Business
Table 59. Sanofi Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Sanofi Latest Developments
Table 61. Novartis Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 62. Novartis Biologic Medication in COVID-19 Product Offered
Table 63. Novartis Main Business
Table 64. Novartis Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Novartis Latest Developments
Table 66. Merck Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 67. Merck Biologic Medication in COVID-19 Product Offered
Table 68. Merck Main Business
Table 69. Merck Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Merck Latest Developments
Table 71. Bayer Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 72. Bayer Biologic Medication in COVID-19 Product Offered
Table 73. Bayer Main Business
Table 74. Bayer Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Bayer Latest Developments
Table 76. Shutaishen Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 77. Shutaishen Biologic Medication in COVID-19 Product Offered
Table 78. Shutaishen Main Business
Table 79. Shutaishen Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Shutaishen Latest Developments
Table 81. Biogen Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 82. Biogen Biologic Medication in COVID-19 Product Offered
Table 83. Biogen Main Business
Table 84. Biogen Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Biogen Latest Developments
Table 86. Regeneron Pharmaceuticals Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 87. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Product Offered
Table 88. Regeneron Pharmaceuticals Main Business
Table 89. Regeneron Pharmaceuticals Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Regeneron Pharmaceuticals Latest Developments
Table 91. Vir Biotech Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 92. Vir Biotech Biologic Medication in COVID-19 Product Offered
Table 93. Vir Biotech Main Business
Table 94. Vir Biotech Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Vir Biotech Latest Developments
Table 96. Junshi Biosciences Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 97. Junshi Biosciences Biologic Medication in COVID-19 Product Offered
Table 98. Junshi Biosciences Main Business
Table 99. Junshi Biosciences Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Junshi Biosciences Latest Developments
Table 101. Anke Biotechnology Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 102. Anke Biotechnology Biologic Medication in COVID-19 Product Offered
Table 103. Anke Biotechnology Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Anke Biotechnology Main Business
Table 105. Anke Biotechnology Latest Developments
Table 106. OncoImmune Details, Company Type, Biologic Medication in COVID-19 Area Served and Its Competitors
Table 107. OncoImmune Biologic Medication in COVID-19 Product Offered
Table 108. OncoImmune Main Business
Table 109. OncoImmune Biologic Medication in COVID-19 Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. OncoImmune Latest Developments
LIST OF FIGURES
Figure 1. Biologic Medication in COVID-19 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologic Medication in COVID-19 Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biologic Medication in COVID-19 Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biologic Medication in COVID-19 Sales Market Share by Country/Region (2023)
Figure 8. Biologic Medication in COVID-19 Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biologic Medication in COVID-19 Market Size Market Share by Type in 2023
Figure 10. Biologic Medication in COVID-19 in COVID-19
Figure 11. Global Biologic Medication in COVID-19 Market: COVID-19 (2019-2024) & ($ Millions)
Figure 12. Biologic Medication in COVID-19 in Influenza
Figure 13. Global Biologic Medication in COVID-19 Market: Influenza (2019-2024) & ($ Millions)
Figure 14. Biologic Medication in COVID-19 in Malaria
Figure 15. Global Biologic Medication in COVID-19 Market: Malaria (2019-2024) & ($ Millions)
Figure 16. Biologic Medication in COVID-19 in Others
Figure 17. Global Biologic Medication in COVID-19 Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Biologic Medication in COVID-19 Market Size Market Share by Application in 2023
Figure 19. Global Biologic Medication in COVID-19 Revenue Market Share by Player in 2023
Figure 20. Global Biologic Medication in COVID-19 Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 22. APAC Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 23. Europe Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 25. Americas Biologic Medication in COVID-19 Value Market Share by Country in 2023
Figure 26. United States Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Biologic Medication in COVID-19 Market Size Market Share by Region in 2023
Figure 31. APAC Biologic Medication in COVID-19 Market Size Market Share by Type in 2023
Figure 32. APAC Biologic Medication in COVID-19 Market Size Market Share by Application in 2023
Figure 33. China Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Biologic Medication in COVID-19 Market Size Market Share by Country in 2023
Figure 40. Europe Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Figure 41. Europe Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Figure 42. Germany Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 56. APAC Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 57. Europe Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 59. United States Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 60. Canada Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 63. China Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 64. Japan Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 65. Korea Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 67. India Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 68. Australia Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 69. Germany Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 70. France Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 71. UK Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 72. Italy Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 73. Russia Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 74. Spain Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 77. Israel Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 80. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biologic Medication in COVID-19 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologic Medication in COVID-19 Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biologic Medication in COVID-19 Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biologic Medication in COVID-19 Sales Market Share by Country/Region (2023)
Figure 8. Biologic Medication in COVID-19 Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biologic Medication in COVID-19 Market Size Market Share by Type in 2023
Figure 10. Biologic Medication in COVID-19 in COVID-19
Figure 11. Global Biologic Medication in COVID-19 Market: COVID-19 (2019-2024) & ($ Millions)
Figure 12. Biologic Medication in COVID-19 in Influenza
Figure 13. Global Biologic Medication in COVID-19 Market: Influenza (2019-2024) & ($ Millions)
Figure 14. Biologic Medication in COVID-19 in Malaria
Figure 15. Global Biologic Medication in COVID-19 Market: Malaria (2019-2024) & ($ Millions)
Figure 16. Biologic Medication in COVID-19 in Others
Figure 17. Global Biologic Medication in COVID-19 Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Biologic Medication in COVID-19 Market Size Market Share by Application in 2023
Figure 19. Global Biologic Medication in COVID-19 Revenue Market Share by Player in 2023
Figure 20. Global Biologic Medication in COVID-19 Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 22. APAC Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 23. Europe Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Biologic Medication in COVID-19 Market Size 2019-2024 ($ Millions)
Figure 25. Americas Biologic Medication in COVID-19 Value Market Share by Country in 2023
Figure 26. United States Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Biologic Medication in COVID-19 Market Size Market Share by Region in 2023
Figure 31. APAC Biologic Medication in COVID-19 Market Size Market Share by Type in 2023
Figure 32. APAC Biologic Medication in COVID-19 Market Size Market Share by Application in 2023
Figure 33. China Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Biologic Medication in COVID-19 Market Size Market Share by Country in 2023
Figure 40. Europe Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Figure 41. Europe Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Figure 42. Germany Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Biologic Medication in COVID-19 Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Biologic Medication in COVID-19 Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 56. APAC Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 57. Europe Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 59. United States Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 60. Canada Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 63. China Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 64. Japan Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 65. Korea Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 67. India Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 68. Australia Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 69. Germany Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 70. France Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 71. UK Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 72. Italy Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 73. Russia Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 74. Spain Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 77. Israel Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Biologic Medication in COVID-19 Market Size 2025-2030 ($ Millions)
Figure 80. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Biologic Medication in COVID-19 Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Cefepime Injection Market Growth 2023-2029
US$ 3,660.00
February 2023
104 pages
Global Cell Separation Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
February 2024
104 pages
Global Softgel Capsules Market Growth 2026-2032
US$ 3,660.00
July 2026
163 pages
Global Dental Bonding Agent Market Growth 2024-2030
US$ 3,660.00
February 2024
105 pages
Global Cleanroom Consumables Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
July 2026
116 pages
